Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,222Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1VIRUPAKSHA ORGANICS LIMITED

02 1Dipharma Francis Srl

03 1Glenmark Life Sciences Limited

04 1HAMARI PFST, Ltd.

05 1Harman Finochem Limited

06 1Kaneka Corporation

07 1Maithri Drugs Private Limited

08 1Mylan Laboratories Limited

09 1Procos S.p.A.

10 1Sumitomo Chemical Company, Limited

11 1Tianish Laboratories Private Limited

12 3Zhejiang Ausun Pharmaceutical Co., Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWith Virupaksha, you get a quality product with on-time delivery.

EFINACONAZOLE

NDC Package Code : 51686-0012

Start Marketing Date : 2007-10-16

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Virupaksha

02

PharmScience R&D
Not Confirmed
arrow

03

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

EFINACONAZOLE

NDC Package Code : 66039-930

Start Marketing Date : 2016-09-30

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

EFINACONAZOLE

NDC Package Code : 51557-001

Start Marketing Date : 2014-06-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER, FOR SOLUTION (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

EFINACONAZOLE

NDC Package Code : 66064-1024

Start Marketing Date : 2017-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (10kg/10kg)

Marketing Category : BULK INGREDIENT

blank

06

PharmScience R&D
Not Confirmed
arrow

07

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

EFINACONAZOLE

NDC Package Code : 46016-1642

Start Marketing Date : 2017-03-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

08

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

EFINACONAZOLE

NDC Package Code : 68259-1314

Start Marketing Date : 2014-07-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER, FOR SOLUTION (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

BioAsia
Not Confirmed
arrow
arrow
BioAsia
Not Confirmed

EFINACONAZOLE

NDC Package Code : 65015-896

Start Marketing Date : 2020-03-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

PharmScience R&D
Not Confirmed
arrow

Looking for 164650-44-6 / Efinaconazole API manufacturers, exporters & distributors?

Efinaconazole manufacturers, exporters & distributors 1

49

PharmaCompass offers a list of Efinaconazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Efinaconazole manufacturer or Efinaconazole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Efinaconazole manufacturer or Efinaconazole supplier.

PharmaCompass also assists you with knowing the Efinaconazole API Price utilized in the formulation of products. Efinaconazole API Price is not always fixed or binding as the Efinaconazole Price is obtained through a variety of data sources. The Efinaconazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Efinaconazole

Synonyms

164650-44-6, (2r,3r)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol, Kp-103, Jublia, Clenafin, Kp103

Cas Number

164650-44-6

Unique Ingredient Identifier (UNII)

J82SB7FXWB

About Efinaconazole

Efinaconazole is a triazole compound, with antifungal activity. Upon administration, efinaconazole targets, binds to and inhibits 14-alpha-demethylase, a cytochrome P450-dependent enzyme. Inhibition of 14-alpha-demethylase prevents the conversion of lanosterol to ergosterol, an important component of the fungal cell wall. Inhibition of ergosterol synthesis changes the fungal cell membrane composition and integrity, alters membrane permeability and eventually leads to fungal cell lysis.

Efinaconazole Manufacturers

A Efinaconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Efinaconazole, including repackagers and relabelers. The FDA regulates Efinaconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Efinaconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Efinaconazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Efinaconazole Suppliers

A Efinaconazole supplier is an individual or a company that provides Efinaconazole active pharmaceutical ingredient (API) or Efinaconazole finished formulations upon request. The Efinaconazole suppliers may include Efinaconazole API manufacturers, exporters, distributors and traders.

click here to find a list of Efinaconazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Efinaconazole NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Efinaconazole as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Efinaconazole API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Efinaconazole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Efinaconazole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Efinaconazole NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Efinaconazole suppliers with NDC on PharmaCompass.

Efinaconazole Manufacturers | Traders | Suppliers

Efinaconazole Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.